|
|
 |
|
Viewing report
|
|
|
|
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (December 2003)
Mergent, Dec 2003, Pages: 40
Current Environment - Key Points
- From May 30 to October 31 2003, the total market capitalization of 100 publicly listed Asia-Pacific biotechnology companies tracked by Mergent rose by 8.88%
- Except for Korea, biotechnology companies operating in the region enjoyed overall increases in their share prices, resulting from an upwards trend in US biotechs that filtered through to Asia
- Expectations of a rise in the number of biotechnology IPOs in the second half of 2003 have not been met, with the majority of new listings being in property, communications, electronics, resources and non-biotech IT sectors instead
- Asia-Pacific biotech companies are increasingly forming alliances with foreign partners to enable their respective products to reach new markets
Industry Profile - Key Points - Asia-Pacific is home to an estimated 12% of the world's public biotech companies
Mergent data shows the Asia-Pacific biotechnology sector is worth around US$80 billion
Start-ups and companies extending business lines are common among Asia-Pacific biotechs
- Governments are continuing to promote biotechnology in their respective industries by establishing technology parks, funding companies and participating in research
- Government-led research into finding a cure for SARS has resulted in detection kits being developed in Taiwan, Hong Kong, China, Japan and Singapore
SARS is expected to return during the northern winter 2003
- Despite SARS, foreign direct investment (FDI) into China for January to September was US$40.2 billion and is expected to top US$57 billion in 2003
The outbreak did not hamper investment in Asia-Pacific
Market Trends and Outlook - Key Points
- Biotechnology has the potential to solve problems including diminishing arable and permanent crop land
The demand for improved agricultural yields has risen
Developing countries (many of which are in Asia-Pacific) are expected to contribute more to world cereal output than developed countries during 2002/03
- The UN Food and Agricultural Organization (FAO) expects deterioration in world cereal stocks after the global stocks-to-use ratio fell to 19% in the 2003/04 period, lower than the 24% in the 2002/03 period
- World cereal prices remain uncertain as harvest outputs deteriorate in Europe, but the resumption of production by Australia, US and Canada is seen to have neutralizing effects on price movements
- Ageing populations in the West and some Asia-Pacific countries, such as Japan, are boosting demand for biopharmaceuticals and medical equipment, which supports biotech R&D
- Demand for generic drugs worldwide and substantial concessions by patent holders have resulted in cheaper versions of patented drugs being produced to help fight diseases such as AIDS and malaria
- Biotechnology has a huge potential in the halal products market, catering to a probable two billion global Muslim population
Customers who bought this item also bought
Asia Pacific Biotechnology Market (2007-2010)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (December 2007)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (June 2007)
Asia Pacific Biotechnology Market (2008-2012)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (July 2003)
Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (August 2008)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (June 2006)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (December 2004)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (December 2005)
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (December 2006)
Asia Pacific Biofuel Market Forecast
Biotechnology in India
|
|
|
|
